User profiles for L.M. Poisson
Laila Marie PoissonHenry Ford Health System Verified email at hfhs.org Cited by 23152 |
[HTML][HTML] The somatic genomic landscape of glioblastoma
We describe the landscape of somatic genomic alterations based on multidimensional and
comprehensive characterization of more than 500 glioblastoma tumors (GBMs). We identify …
comprehensive characterization of more than 500 glioblastoma tumors (GBMs). We identify …
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Multiple, complex molecular events characterize cancer development and progression 1 , 2
. Deciphering the molecular networks that distinguish organ-confined disease from …
. Deciphering the molecular networks that distinguish organ-confined disease from …
[PDF][PDF] An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson… - Cell, 2018 - cell.com
For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic
annotation data along with multi-platform molecular profiles of more than 11,000 human tumors …
annotation data along with multi-platform molecular profiles of more than 11,000 human tumors …
[BOOK][B] Poisson structures
C Laurent-Gengoux, A Pichereau, P Vanhaecke - 2012 - books.google.com
… be derived from the general concept of a Poisson algebra, so we faced the challenge of …
of a Poisson algebra, of a Poisson variety, of a Poisson manifold and of a Poisson morphism…
of a Poisson algebra, of a Poisson variety, of a Poisson manifold and of a Poisson morphism…
[HTML][HTML] “Omics” data and levels of evidence for biomarker discovery
D Ghosh, LM Poisson - Genomics, 2009 - Elsevier
With the development of new technologies for assaying biological activity on a global basis
in experimental samples, various new “-omics” signatures have been developed to predict …
in experimental samples, various new “-omics” signatures have been developed to predict …
[PDF][PDF] Glioma progression is shaped by genetic evolution and microenvironment interactions
…, T Weiss, M Weller, K Palucka, LF Stead, LM Poisson… - Cell, 2022 - cell.com
The factors driving therapy resistance in diffuse glioma remain poorly understood. To
identify treatment-associated cellular and genetic changes, we analyzed RNA and/or DNA …
identify treatment-associated cellular and genetic changes, we analyzed RNA and/or DNA …
Deep-learning convolutional neural networks accurately classify genetic mutations in gliomas
BACKGROUND AND PURPOSE: The World Health Organization has recently placed new
emphasis on the integration of genetic information for gliomas. While tissue sampling remains …
emphasis on the integration of genetic information for gliomas. While tissue sampling remains …
Longitudinal molecular trajectories of diffuse glioma in adults
The evolutionary processes that drive universal therapeutic resistance in adult patients with
diffuse glioma remain unclear 1 , 2 . Here we analysed temporally separated DNA-…
diffuse glioma remain unclear 1 , 2 . Here we analysed temporally separated DNA-…
Estimating post-traumatic stress disorder in the community: lifetime perspective and the impact of typical traumatic events
N Breslau, EL Peterson, LM Poisson… - Psychological …, 2004 - cambridge.org
Background. Community surveys have assessed post-traumatic stress disorder (PTSD) in
relation to traumatic events designated by respondents as the worst they have ever …
relation to traumatic events designated by respondents as the worst they have ever …
T2–FLAIR mismatch, an imaging biomarker for IDH and 1p/19q status in lower-grade gliomas: a TCGA/TCIA project
Purpose: Lower-grade gliomas (WHO grade II/III) have been classified into clinically
relevant molecular subtypes based on IDH and 1p/19q mutation status. The purpose was to …
relevant molecular subtypes based on IDH and 1p/19q mutation status. The purpose was to …